USPTO serial 79440839
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ashly I. Boesche
Ashly I. Boesche PATTISHALL, MCAULIFFE, NEWBURY, HILLIARD125 S Wacker DriveSuite 2050CHICAGO, IL 60606| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of diabetes and obesity, pharmaceutical preparations for haemostasis management and for the treatment of sickle cell disease; pharmaceutical preparations for the treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease; pharmaceutical preparations for hormone therapy and stem cells for medical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; chemical preparations for medical use. | ACTIVE | — |
| 009 | Downloadable software in mobile applications for telehealth and telemedicine offerings for use by patients and healthcare professionals; downloadable software from websites for use by patients and healthcare professionals for the treatment of medical conditions; downloadable software for enabling patients to access general medical, health, and wellness information and advice; downloadable software for management and dispensing of medical prescriptions. | ACTIVE | — |
| 016 | Instructional and teaching material. | ACTIVE | — |
| 035 | Promoting public awareness about medical conditions; online business services in the nature of retail pharmacy services for the ordering, purchase, and delivery of pharmaceutical preparations, location of healthcare professional, coordination of direct-to-consumer delivery of medicine. | ACTIVE | — |
| 036 | Providing financial assistance to patients and healthcare providers for prescription pharmaceutical costs; providing information about patient reimbursement and insurance coverage for pharmaceuticals. | ACTIVE | — |
| 041 | Educational services, namely, educational programmes, online electronic publication of reports, newsletters, and articles, online coaching and training services for patients and healthcare professionals related to the treatment of medical conditions. | ACTIVE | — |
| 042 | Platform as a service featuring computer software to permit users to identify, request and receive pharmacy products. | ACTIVE | — |
| 044 | Providing information in the field of management of medical conditions; charitable services, namely, patient assistance program to provide pharmaceuticals free of charge to low-income patients without prescription drug coverage. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 12, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 12, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 12, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 30, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 13, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 13, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 7, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 6, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 3, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 15, 2026 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jan 2, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 2, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 1, 2026 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |